Mitigation of photodamage in analytical reactions

• US 7,993,895 B2
• Filed: 12/01/2006
• Issued: 08/09/2011
• Est. Priority Date: 12/02/2005
• Status: Active Grant

• Current Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Original Assignee: Pacific Bioscience of California Incorporated (L'Oreal SA)
• Inventors: Eid, John, Otto, Geoffrey, Murphy, Devon, Turner, Stephen
• Primary Examiner(s): Saucier; Sandra
• Assistant Examiner(s): Hanley; Susan
• Application Number:
  US11/566,153
• Publication Number:
  US 20070161017A1
• Time in Patent Office: 1,712 Days
• Field of Search: 435/91.1, 435/183, 435/193, 424/94.1, 424/94.5
• US Class Current: 435/193
• CPC Class Codes: A61K 38/063 Glutathione
• CPC Class Codes: A61K 38/443 acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
• CPC Class Codes: A61K 38/446 Superoxide dismutase (1.15)
• CPC Class Codes: G01N 33/582 with fluorescent label

Abstract

Compositions, devices, systems and methods for reducing and/or preventing photodamage of one or more reactants in illuminated analytical reactions by one or more of incorporating photodamage mitigating agents within the reaction mixture and/or interrogating different observation regions of the reaction mixture for a period that is less than a photodamage threshold period.

Claims

1. A composition, comprising:

a first reactant, wherein the first reactant comprises a polymerase;

a second reactant, wherein the second reactant comprises a fluorescent or fluorogenic substrate for the polymerase; and

more than one different photodamage mitigating agent present in a concentration sufficient to reduce photodamage to the polymerase when the first and second reactant are subjected to an excitation illumination for the second reactant;

wherein interaction of the first reactant with the second reactant under excitation illumination causes photodamage to the first reactant in the absence of the more than one different photodamage mitigating agent.

2. The composition of claim 1, wherein the first reactant is present in a limited quantity;

wherein the limited quantity is between one and ten molecules of the first reactant.

3. The composition of claim 1, wherein the first reactant is present at a concentration of less than 200 nM.

4. The composition of claim 1, wherein the first reactant is present at a concentration of at less than 10 nM.

5. The composition of claim 1, wherein the first reactant is present at a concentration of less than 10 pM.

6. The composition of claim 1, wherein the first reactant is immobilized upon a surface.

7. The composition of claim 6, wherein the surface comprises a surface of an optical confinement.

8. The composition of claim 7, wherein the optical confinement comprises a zero mode waveguide.

9. The composition of claim 1, wherein the first reactant is confined within a first area.

10. The composition of claim 9, wherein there are from 1 to 3 molecules of the first reactant immobilized within the first area.

11. The composition of claim 9, wherein the first area comprises an optical confinement.

12. The composition of claim 11, wherein the optical confinement comprises a zero mode waveguide.

13. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise a triplet state quencher.

14. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise an antioxidant.

15. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise a singlet oxygen scavenger or singlet oxygen quencher.

16. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise at least one agent selected from the group consisting of ascorbic acid, dithiothreitol, mercaptoethylamine, beta-mercaptoethanol, n-propyl gallate, p-phenylenediamine, hydroquinone, sodium azide, diazobicyclooctane, Trolox, butylated hydroxytoluene and cyclooctatetraene.

17. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise an oxygen depleting enzyme.

18. The composition of claim 17, wherein the oxygen depleting enzyme comprises an enzyme selected from the group consisting of super oxide dismutase, glucose oxidase, cholesterol oxidase, lactate oxidase, pyruvate oxidase, xanthine oxidase and protocatachaute 3,4 dioxygenase.

19. The composition of claim 17, further comprising a peroxide depleting enzyme selected from the group of catalase, horseradish peroxidase and glutathione peroxidase.

20. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise a glucose-oxidase/catalase enzyme system.

21. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise at least one agent selected from the group consisting of ergothionine, methionine, cysteine, beta-dimethyl cysteine, histidine, tryptophan, mercaptopropionylglycine, 2-mercaptoethane sulfonate sodium, glutathione, dithiothreitol, N-acetyl cysteine, captopril, lycopene, gamma-carotene, astazanthin, canthazanthin, alpha-carotene, beta-carotene, gamma carotene bixin, zeaxanthin, lutein, bilirubin, biliverdin, tocopherols, polyene dialdehydes, melatonin, alpha-tocopheryl succinate, pyridoxinel, hydrazine, sodium sulfite, and hydroxylamine.

22. The composition of claim 1, wherein the more than one different photodamage mitigating agent comprise dithiothreitol and mercaptoethylamine.

23. The composition of claim 1, wherein the polymerase is a DNA polymerase.

24. The composition of claim 1, further comprising a template nucleic acid and a primer.

25. The composition of claim 1, wherein the substrate for the polymerase comprises a fluorescent or fluorogenic nucleotide analog.

26. The composition of claim 25, wherein the nucleotide or nucleotide analog comprises a polyphosphate comprising four phosphate groups.

27. A composition, comprising:

a confined polymerase;

a fluorescent or fluorogenic substrate for said polymerase and

photodamage mitigating agents comprising more than one different triplet state quencher present in a concentration sufficient to reduce photodamage to the polymerase when the polymerase and the fluorescent or fluorogenic substrate are subjected to excitation illumination for the fluorescent or fluorogenic substrate wherein interaction of the enzyme with the fluorescent or fluorogenic substrate under excitation illumination for the fluorescent or fluorogenic substrate causes photodamage to the polymerase in the absence of the photodamage mitigating agents.

28. The composition of claim 27, wherein at least one of the more than one different triplet state quencher is selected from the group consisting of ascorbic acid, dithiothreitol, mercaptoethylamine, n-propyl gallate, p-phenylenediamine, hydroquinone, sodium azide, cyclooctatetraene and diazobicyclooctane.

29. The composition of claim 27, wherein the photodamage mitigating agents further comprise a singlet oxygen scavenger or singlet oxygen quencher.

30. The composition of claim 27, wherein the photodamage mitigating agents comprise dithiothreitol and mercaptoethylamine.

31. The composition of claim 27, wherein the photodamage mitigating agents further comprise a glucose-oxidase/catalase enzyme system.

32. The composition of claim 27, wherein the confined enzyme is immobilized to a surface of a substrate.

33. The composition of claim 27, wherein the substrate for the confined polymerase is a fluorescent or fluorogenic nucleotide or nucleotide.

34. The composition of claim 33, wherein the fluorescent or fluorogenic nucleotide or nucleotide analog comprises a polyphosphate comprising four phosphate groups.

35. The composition of claim 27, wherein the polymerase is a DNA polymerase.

36. A device, comprising:

a substrate having an observation region;

a first reactant immobilized within the observation region, wherein the first reactant comprises a polymerase;

a second reactant comprising a fluorescent or fluorogenic substrate for the polymerase disposed within the observation region, wherein interaction between the first and second reactants under excitation illumination causes photodamage to both the fluorescent of fluorogenic substrate and the first reactant; and

more than one different photodamage mitigating agent that are present in a concentration sufficient to reduce photodamage to the polymerase when the first and second reactant are subjected to an excitation illumination wavelength for the second reactant disposed within the observation region.

37. The device of claim 36, wherein the fluorescent or fluorogenic substrate for the polymerase is a nucleotide or nucleotide analog.

38. The device of claim 37, wherein the nucleotide or nucleotide analog comprises a polyphosphate comprising four phosphate groups.

39. The device of claim 37, wherein the excitation illumination causes photodamage to the fluorescent or fluorogenic substrate.

40. The device of claim 36, wherein the polymerase is a DNA polymerase.